MARATTO

article · RSC Medicinal Chemistry

Design, synthesis and characterization of novel pyridazin-3-one derivatives: <i>in vitro</i> vasorelaxant activity and <i>in silico</i> insights into eNOS modulation

20251 citationOpen accessSinai University

In plain language

The abstract on record is too brief for a reliable plain-language summary, so none has been generated.

Abstract

Two novel series of pyridazin-3-ones, designed as potential vasodilators, demonstrated superior aortic vasorelaxant activity, eNOS mRNA expression and nitric oxide up-levelling.

Research topics

  • Synthesis and Catalytic Reactions
  • Nitric Oxide and Endothelin Effects
  • Organic Chemistry Cycloaddition Reactions

Read the original research

This page summarises published work. The authoritative version sits with the publisher.

DOI: 10.1039/d4md00998c

Is something wrong with this record? Report it or request removal.

Discussion

Discuss this research

Have you built on this work, tried to replicate it, or seen it applied in practice? Share what you know. Verified researchers and MARATTO™ domain experts can open a discussion, and any member can reply. Contributions are reviewed before they appear.

No discussion yet. Open the first thread.